Prolonged lyme disease treatment: Enough is enough

Neurology

Volumn 71, Issue 17, 2008, Pages 1379-1380

  Ricks, Patricia W B ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CEFTRIAXONE; ANTIINFECTIVE AGENT; ANTIBIOTIC AGENT; ISONIAZID; RIFAMPICIN;

ANTIBIOTIC THERAPY; CHRONIC DISEASE; COGNITION; DISEASE SEVERITY; DRUG EFFICACY; DRUG WITHDRAWAL; HUMAN; LETTER; LYME DISEASE; PATIENT CARE; PHYSICAL PERFORMANCE; PRIORITY JOURNAL; THERAPY EFFECT; TREATMENT DURATION; UNITED STATES; NOTE; PATHOPHYSIOLOGY; TIME; TREATMENT OUTCOME; BACTERIAL VIRULENCE; BORRELIA BURGDORFERI; COLOMBIA; CONGESTIVE HEART FAILURE; DRUG TREATMENT FAILURE; MULTIDRUG RESISTANT TUBERCULOSIS; QUALITY OF LIFE; SPIROCHETE;

ANTI-BACTERIAL AGENTS; HUMANS; LYME DISEASE; TIME FACTORS; TREATMENT OUTCOME;

MLCS; MLOWN;

EID: 55449099110     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/01.wnl.0000338444.31486.8f     Document Type: Letter

References (2)

1. Halperin JJ Prolonged Lyme disease treatment Neurology 70 2008 986 987
2. Fallon BA Keilp JG Corbera KM A randomized, placebo-controlled trial of repeated intravenous antibiotic therapy for Lyme encephalopathy Neurology 70 2008 992 1003